Literature DB >> 17259695

Alteration of heart rate variability parameters in nondiabetic hemodialysis patients.

Yan-Qing Tong1, Huo-Ming Hou.   

Abstract

OBJECTIVE: We attempt to identify heart rate variability (HRV) components and decide whether or not such components are more sensitive to the hemodialysis (HD) process by excluding the presence of comorbid conditions known to affect HRV.
METHODS: It was a prospective cohort study of factors associated with HRV. Thirty-five HD patients were admitted to the study. The research was divided into three phases. During the first phase, baseline Holter and blood pressure recordings were carried out. Then in the second phase, the patients were admitted for HD with continuous Holter and blood pressure recording. The third phase was after HD with continuous Holter and blood pressure recording. The frequency and time domain analyses of HRV were carried out by an independent, blinded investigator. Plasma Na+, K+, ionized Ca, hemoglobin, serum creatinine and blood urea nitrogen (BUN) were checked 1 h before and 2 h after HD.
RESULTS: After HD, the serum creatinine and BUN were obviously reduced (p < 0.01), which was also expressed by fractional urea clearance (K(t)/V; 1.55 +/- 0.25), which means efficient HD. Standard deviation of all RR intervals and low-frequency/high-frequency (LF/HF) ratio were reduced significantly (p < 0.05) at the 'HD for 3 h' time point while the blood pressure levels were relatively stable during the HD process. The ultrafiltration rate and K(t)/V appeared to be the main determinants of the LF/HF ratio in HD. In our cases, the LF/HF ratio positively correlated with K(t)/V and negatively correlated with ultrafiltration volume.
CONCLUSION: Our study suggested a shift in sympathovagal balance toward sympathetic activation during the HD process. Sympathetic overactivity is positively correlated with the ultrafiltration rate, and negatively correlated with the K(t)/V which means that the HD process itself affects HRV parameters indeed. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17259695     DOI: 10.1159/000099013

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  14 in total

Review 1.  The potential of electrocardiography for cardiac risk prediction in chronic and end-stage kidney disease.

Authors:  Sofia Skampardoni; Dimitrios Poulikakos; Marek Malik; Darren Green; Philip A Kalra
Journal:  Nephrol Dial Transplant       Date:  2019-07-01       Impact factor: 5.992

Review 2.  A brief review of intradialytic hypotension with a focus on survival.

Authors:  Jason A Chou; Kamyar Kalantar-Zadeh; Anna T Mathew
Journal:  Semin Dial       Date:  2017-06-29       Impact factor: 3.455

Review 3.  Antihypertensive Agents in the Dialysis Patient.

Authors:  Michelle A Fravel; Elizabeth Bald; Mony Fraer
Journal:  Curr Hypertens Rep       Date:  2019-01-18       Impact factor: 5.369

4.  Effect of icodextrin on heart rate variability in diabetic patients on peritoneal dialysis.

Authors:  Oscar Orihuela; María de Jesús Ventura; Marcela Ávila-Díaz; Alejandra Cisneros; Marlén Vicenté-Martínez; María-del-Carmen Furlong; Zuzel García-González; Diana Villanueva; Guadalupe Alcántara; Bengt Lindholm; Elvia García-López; Cleva Villanueva; Ramón Paniagua
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

Review 5.  Prognostic significance and therapeutic option of heart rate variability in chronic kidney disease.

Authors:  Jing Zhang; Ningning Wang
Journal:  Int Urol Nephrol       Date:  2013-03-29       Impact factor: 2.370

Review 6.  The management of diabetic neuropathy in CKD.

Authors:  Rodica Pop-Busui; Laurel Roberts; Subramaniam Pennathur; Mathias Kretzler; Frank C Brosius; Eva L Feldman
Journal:  Am J Kidney Dis       Date:  2009-12-30       Impact factor: 8.860

7.  Sympathetic hyperactivity influences chemosensor function in patients with end-stage renal disease.

Authors:  C Meyer; P Schueller; J Balzer; T Lauer; R Westenfeld; P Schauerte; M Hennersdorf; S Steiner; M Kelm; T Rassaf
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

8.  Prognostic indicators of cardiovascular risk in renal disease.

Authors:  Cara M Hildreth
Journal:  Front Physiol       Date:  2012-01-12       Impact factor: 4.566

9.  Modulation of peripheral chemoreflex by neurohumoral adaptations after kidney transplantation.

Authors:  T Rassaf; R Westenfeld; J Balzer; T Lauer; M Merx; J Floege; S Steiner; C Heiss; M Kelm; Christian Meyer
Journal:  Eur J Med Res       Date:  2010-11-04       Impact factor: 2.175

10.  Link between Peripheral Artery Disease and Heart Rate Variability in Hemodialysis Patients.

Authors:  Szu-Chia Chen; Chien-Fu Chen; Jiun-Chi Huang; Mei-Yueh Lee; Jui-Hsin Chen; Jer-Ming Chang; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  PLoS One       Date:  2015-08-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.